BEAM
Price
$29.57
Change
+$1.49 (+5.31%)
Updated
Dec 1, 6:59 PM EST
85 days until earnings call
HRTX
Price
$1.32
Change
+$0.09 (+7.32%)
Updated
Dec 1, 6:59 PM EST
85 days until earnings call
Ad is loading...

Compare predictions BEAM vs HRTX

Header iconBEAM vs HRTX Comparison
Open Charts BEAM vs HRTXBanner chart's image
Beam Therapeutics
Price$29.57
Change+$1.49 (+5.31%)
Volume$600.39K
CapitalizationN/A
Heron Therapeutics
Price$1.32
Change+$0.09 (+7.32%)
Volume$1.46M
CapitalizationN/A
View a ticker or compare two or three
BEAM vs HRTX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BEAM vs. HRTX commentary
Dec 04, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and HRTX is a Buy.

COMPARISON
Comparison
Dec 04, 2023
Stock price -- (BEAM: $29.57 vs. HRTX: $1.32)
Brand notoriety: BEAM and HRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. HRTX: 80%
Market capitalization -- BEAM: $2.38B vs. HRTX: $198.1M
BEAM [@Biotechnology] is valued at $2.38B. HRTX’s [@Biotechnology] market capitalization is $198.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileHRTX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • HRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while HRTX’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • HRTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than HRTX.

Price Growth

BEAM (@Biotechnology) experienced а -0.34% price change this week, while HRTX (@Biotechnology) price change was -4.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

BEAM is expected to report earnings on Feb 27, 2024.

HRTX is expected to report earnings on Feb 27, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for HRTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($2.38B) has a higher market cap than HRTX($198M). BEAM YTD gains are higher at: -24.393 vs. HRTX (-47.200). HRTX has higher annual earnings (EBITDA): -122.67M vs. BEAM (-379.73M). BEAM has more cash in the bank: 1.02B vs. HRTX (77.4M). BEAM (173M) and HRTX (180M) have identical debt. HRTX has higher revenues than BEAM: HRTX (123M) vs BEAM (81.6M).
BEAMHRTXBEAM / HRTX
Capitalization2.38B198M1,201%
EBITDA-379.73M-122.67M310%
Gain YTD-24.393-47.20052%
P/E RatioN/AN/A-
Revenue81.6M123M66%
Total Cash1.02B77.4M1,311%
Total Debt173M180M96%
FUNDAMENTALS RATINGS
HRTX: Fundamental Ratings
HRTX
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMHRTX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 7 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ROFCX11.320.28
+2.54%
Royce Small-Cap Opportunity Consult
LHCFX16.840.17
+1.02%
Lord Abbett Health Care F
LCSTX22.940.22
+0.97%
ClearBridge Sustainability Leaders FI
PINRX12.920.11
+0.86%
Principal Diversified Intl R3
SGQCX33.350.18
+0.54%
DWS International Growth C

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with MDGL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
+7.32%
MDGL - HRTX
49%
Loosely correlated
+4.83%
AMRN - HRTX
44%
Loosely correlated
-4.09%
ORMP - HRTX
43%
Loosely correlated
-4.05%
BEAM - HRTX
42%
Loosely correlated
+5.31%
EDIT - HRTX
41%
Loosely correlated
+2.28%
More